As a global meeting services organization, AMI represents many clients in the pharmaceutical industry, planning hundreds of meetings and events including Advisory Boards, Congresses, HCP Meetings, Internal Meetings, Investigator Meetings, Product Launches, Speaker Trainings, and more. We constantly seek out opportunities to stay up-to-date with the latest trends, discover new resources, and develop relationships that will enhance our ability to create winning strategies and best serve the needs of our clients.
The Annual Pharma Forum provided an excellent opportunity to gain valuable knowledge, insights, and connections for the benefit of our pharmaceutical clients. What’s it all about and what do we hope to gain from sponsoring, exhibiting, and attending this event?
What is the Annual Pharma Forum?
The Annual Pharma Forum is “the world’s leading life sciences meeting management conference”, featuring industry-leading speakers; expert panels; topics exploring new technology, compliance challenges, and best practices; and of course, breakout sessions and opportunities for one-on-one networking with medical and pharmaceutical clients, suppliers, and third-party meeting and event organizers.
What Were Some of the Highlights This Year?
This year’s Pharma Forum included a variety of notable speakers and timely topics like industry best practices, notable technologies, and collaborations between corporations and third-party planners. AMI would like to extend a special thank you to all of the Meetings Industry Suppliers who attended The American Meetings Network’s Partners Reception, held at The View on the 48th floor of The Marriott Marquis. The breathtaking panoramic view of New York City provided an ideal backdrop for networking with the Meetings Industry’s leading Suppliers.
How Will AMI Clients Benefit?
AMI is excited to learn about challenges and innovations affecting the pharmaceutical and adjacent industries, as well as the impact of collaborations with third-party service providers like meeting and event planners.